Popular
Octane Aesthetics Tech Forum: Clinical Insights Shaping 2026
Modern AestheticsOctane Aesthetics Tech Forum: Clinical Insights Shaping 2026
Octane Aesthetics Tech Forum: Successfully Disrupting Your Practice in 2026
Modern AestheticsOctane Aesthetics Tech Forum: Successfully Disrupting Your Practice in 2026
Octane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
Modern AestheticsOctane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
Programs
Octane Aesthetics Tech Forum: Structural Adipose Tissue is Next Frontier
Modern AestheticsOctane Aesthetics Tech Forum: Structural Adipose Tissue is Next Frontier
Octane Aesthetics Tech Forum: Artificial Intelligence’s Expanding Role in Aesthetic Medicine
Modern AestheticsOctane Aesthetics Tech Forum: Artificial Intelligence’s Expanding Role in Aesthetic Medicine
Octane Aesthetics Tech Forum: What is Next for GLP-1 RAs and Aesthetic Innovation
Modern AestheticsOctane Aesthetics Tech Forum: What is Next for GLP-1 RAs and Aesthetic Innovation
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®Cosibelimab Delivers Durable Responses in Advanced CSCC
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstractsImproving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Clinical Practice
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstractsSwitching to Risdiplam Maintains Motor Gains in SMA Patients
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
NeuroFrontiersCK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®Expanding Molecular Testing in Community NSCLC Care
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstractsUnderstanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Doctors Lounge
Disparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Clinician's RoundtableDisparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple SclerosisMS Management: Strategies for Ensuring Equitable Access to Teleneurology
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's RoundtableArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
CME
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
MinuteCE®Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management
Heart MattersMasterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management
Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
MinuteCE®Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
Industry Feature
Expert Opinions on Renal Compensation and Renal Functional Reserve
Medical Industry FeatureExpert Opinions on Renal Compensation and Renal Functional Reserve
Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry FeatureTau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Improving Outcomes and Reducing Delays in Orthopedic Surgery
Medical Industry FeatureImproving Outcomes and Reducing Delays in Orthopedic Surgery
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry FeatureTreating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
Medical Industry FeatureResearch Uncovers a Potential Biomarker for Postpartum Depression Risk